The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The INRange RCT

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 217 participants.

Also called NCT02376803

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 217 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02376803
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02376803. Randomized; no masking; primary purpose treatment. Start 2015-02 (registry gives no type); primary completion 2016-09-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT
Condition
Thrombus Due to Heart Valve Prosthesis
Condition
Deep Venous Thrombosis
Condition
Thromboembolism
Intervention (Drug)
Warfarin
Lead sponsor
University of Alberta (class: other)
Collaborator
Vancouver Coastal Health Research Institute (class: other)

Record details

Record id
cardio:ct-nct02376803
Content hash
25277468ab9888e7eb2f7e17eb487eaac852de121de739df77dacafa290266b6